Koshinski Asset Management’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Koshinski Asset Management’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-23,005	Closed	-$492	–	399
2019 Q1	$492	Buy	23,005 +2,700	+13%	+$57.8K	0.13%	199
2018 Q4	$434K	Buy	20,305 +330	+2%	+$7.54K	0.11%	234
2018 Q3	$507K	Buy	19,975 +9,010	+82%	+$229K	0.07%	322
2018 Q2	$276K	Buy	10,965 +2,190	+25%	+$54.1K	0.08%	302
2018 Q1	$216K	Buy	+8,775	New	+$225K	0.07%	333

Other funds holding LDRS

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Koshinski Asset Management's LDRS Position: Q2 2019 in Review

Koshinski Asset Management sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q2 2019, closing a stake of 23,005 shares — an estimated $492 sold.

Koshinski Asset Management first reported a position in LDRS in Q1 2018 and held it in 5 quarters. The position peaked at $507K in Q3 2018. 11 funds tracked by Wall St. Rank hold LDRS as of Q2 2019.

Koshinski Asset Management reported no remaining Innovator IBD ETF Leaders ETF position as of Q2 2019 after selling out during the quarter.
Koshinski Asset Management sold 23,005 Innovator IBD ETF Leaders ETF shares in Q2 2019, an estimated $492.
Koshinski Asset Management first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 5 quarters.
Koshinski Asset Management's Innovator IBD ETF Leaders ETF position peaked at $507K in Q3 2018.
11 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q2 2019.

Based on Koshinski Asset Management's 13F filing for Q2 2019, filed 18 Jul 2019.